Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Calas

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Nature Biotechnology|August 14, 1998
Computer-assisted rational design of immunosuppressive compoundsG Grassy, B Calas, A Yasri, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000
Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificityC Rousselle, M Smirnova, P Clair, et al.
Biochemical Society Transactions|May 1, 1995
A basic residue C-terminal to tyrosine compromises its viability as a tyrosine kinase targetN E Keane, P G Quirk, B A Levine, et al.
FEBS Letters|March 25, 1996
Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formationM E Mangoni, A Aumelas, P Charnet, et al.
European Journal of Biochemistry|December 1, 1994
Structural determinants of substrate selection by the human insulin-receptor protein-tyrosine kinaseN E Keane, A Chavanieu, P G Quirk, et al.
The EMBO Journal|May 15, 1994
Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane rufflingK Kotani, K Yonezawa, K Hara, et al.
Biochemistry|November 26, 1999
The interface between caldesmon domain 4b and subdomain 1 of actin studied by nuclear magnetic resonance spectroscopyY Gao, V B Patchell, P A Huber, et al.
Acta Crystallographica. Section D, Biological Crystallography|October 27, 2001
Expression, purification, crystallization and preliminary X-ray analysis of the cathelicidin motif of the protegrin-3 precursorJ F Sanchez, F Hoh, M P Strub, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Nature Biotechnology|August 14, 1998
Computer-assisted rational design of immunosuppressive compoundsG Grassy, B Calas, A Yasri, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000
Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificityC Rousselle, M Smirnova, P Clair, et al.
Biochemical Society Transactions|May 1, 1995
A basic residue C-terminal to tyrosine compromises its viability as a tyrosine kinase targetN E Keane, P G Quirk, B A Levine, et al.
FEBS Letters|March 25, 1996
Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formationM E Mangoni, A Aumelas, P Charnet, et al.
European Journal of Biochemistry|December 1, 1994
Structural determinants of substrate selection by the human insulin-receptor protein-tyrosine kinaseN E Keane, A Chavanieu, P G Quirk, et al.
The EMBO Journal|May 15, 1994
Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane rufflingK Kotani, K Yonezawa, K Hara, et al.
Biochemistry|November 26, 1999
The interface between caldesmon domain 4b and subdomain 1 of actin studied by nuclear magnetic resonance spectroscopyY Gao, V B Patchell, P A Huber, et al.
Acta Crystallographica. Section D, Biological Crystallography|October 27, 2001
Expression, purification, crystallization and preliminary X-ray analysis of the cathelicidin motif of the protegrin-3 precursorJ F Sanchez, F Hoh, M P Strub, et al.
Pageof 5